Across TCGA pan-cancer cohorts, RPS26 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated RPS26 data layer compared with 26 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher RPS26 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RPS26 expression acts as an unfavorable survival marker, although some lineages such as LSCC and LUAD show a favorable association.

CCRCC, GBM, and PDAC are the cancer types where RPS26 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Quartile	All	0.682	0.991	.001	51	view →
GBM	DFS	Quartile	All	0.209	0.406	.010	10	view →
PDAC	DFS	Median	IV	0.214	0.785	.006	9	view →
LSCC	DFS	Quartile	II,III,IV	1.000	0.386	.024	5	view →
LUAD	DFS	Tertile	All	0.956	0.769	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS26 tumor-vs-normal RNA expression · all RPS26 data types